Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

Beta-3 adrenergic receptor (β3AR) agonists have been shown to produce vasodilation and prevention of ventricular remodeling in different conditions. Given that these biological functions are critical in pulmonary hypertension (PH), we aimed to demonstrate a beneficial effect of β3AR agonists in PH....

Descripción completa

Detalles Bibliográficos
Autores principales: García-Álvarez, Ana, Pereda, Daniel, García-Lunar, Inés, Sanz-Rosa, David, Fernández-Jiménez, Rodrigo, García-Prieto, Jaime, Nuño-Ayala, Mario, Sierra, Federico, Santiago, Evelyn, Sandoval, Elena, Campelos, Paula, Agüero, Jaume, Pizarro, Gonzalo, Peinado, Víctor I., Fernández-Friera, Leticia, García-Ruiz, José M., Barberá, Joan A., Castellá, Manuel, Sabaté, Manel, Fuster, Valentín, Ibañez, Borja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916192/
https://www.ncbi.nlm.nih.gov/pubmed/27328822
http://dx.doi.org/10.1007/s00395-016-0567-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916192/
https://www.ncbi.nlm.nih.gov/pubmed/27328822
http://dx.doi.org/10.1007/s00395-016-0567-0

Ejemplares similares